Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) has a cash flow conversion efficiency ratio of 0.247x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$413.08 Million ≈ $81.05 Million USD) by net assets (R$1.67 Billion ≈ $328.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Profarma Distribuidora de Produtos Farma balance sheet independence to measure how much of total assets are equity-financed.
Profarma Distribuidora de Produtos Farmacêuticos S.A - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Profarma Distribuidora de Produtos Farmacêuticos S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Profarma Distribuidora de Produtos Farma earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Profarma Distribuidora de Produtos Farmacêuticos S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Profarma Distribuidora de Produtos Farmacêuticos S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Omega Oil & Gas Ltd
AU:OMA
|
-0.026x |
|
Maeil Dairies Co. Ltd
KQ:267980
|
0.035x |
|
SANIONA AB (PUBL)
F:30S
|
-0.121x |
|
GRAPHENE MANUFACT.GROUP
F:0GF
|
N/A |
|
TrueBlue Inc
NYSE:TBI
|
-0.038x |
|
Diffusion Engineers Ltd
NSE:DIFFNKG
|
0.036x |
|
Indo Thai Securities Limited
NSE:INDOTHAI
|
0.032x |
|
Superkrane Mitra Utama Tbk PT
JK:SKRN
|
0.091x |
Annual Cash Flow Conversion Efficiency for Profarma Distribuidora de Produtos Farmacêuticos S.A (2003–2024)
The table below shows the annual cash flow conversion efficiency of Profarma Distribuidora de Produtos Farmacêuticos S.A from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see PFRM3 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$1.59 Billion ≈ $311.17 Million |
R$497.09 Million ≈ $97.54 Million |
0.313x | +84.91% |
| 2023-12-31 | R$1.54 Billion ≈ $301.98 Million |
R$260.90 Million ≈ $51.19 Million |
0.170x | +102.72% |
| 2022-12-31 | R$1.51 Billion ≈ $296.41 Million |
R$126.32 Million ≈ $24.79 Million |
0.084x | +14.73% |
| 2021-12-31 | R$1.48 Billion ≈ $289.60 Million |
R$107.58 Million ≈ $21.11 Million |
0.073x | +165.89% |
| 2020-12-31 | R$1.44 Billion ≈ $281.62 Million |
R$39.34 Million ≈ $7.72 Million |
0.027x | -78.42% |
| 2019-12-31 | R$1.00 Billion ≈ $197.13 Million |
R$127.61 Million ≈ $25.04 Million |
0.127x | +332.27% |
| 2018-12-31 | R$1.02 Billion ≈ $200.38 Million |
R$-55.84 Million ≈ $-10.96 Million |
-0.055x | +21.29% |
| 2017-12-31 | R$745.93 Million ≈ $146.37 Million |
R$-51.83 Million ≈ $-10.17 Million |
-0.069x | +50.85% |
| 2016-12-31 | R$758.96 Million ≈ $148.92 Million |
R$-107.29 Million ≈ $-21.05 Million |
-0.141x | -259.33% |
| 2015-12-31 | R$667.95 Million ≈ $131.06 Million |
R$59.27 Million ≈ $11.63 Million |
0.089x | +3.83% |
| 2014-12-31 | R$688.85 Million ≈ $135.17 Million |
R$58.87 Million ≈ $11.55 Million |
0.085x | +154.26% |
| 2013-12-31 | R$571.56 Million ≈ $112.15 Million |
R$-90.02 Million ≈ $-17.66 Million |
-0.158x | -1106.54% |
| 2012-12-31 | R$570.93 Million ≈ $112.03 Million |
R$8.93 Million ≈ $1.75 Million |
0.016x | -71.64% |
| 2011-12-31 | R$541.47 Million ≈ $106.25 Million |
R$29.88 Million ≈ $5.86 Million |
0.055x | -35.52% |
| 2010-12-31 | R$518.89 Million ≈ $101.82 Million |
R$44.40 Million ≈ $8.71 Million |
0.086x | -48.24% |
| 2009-12-31 | R$485.37 Million ≈ $95.24 Million |
R$80.25 Million ≈ $15.75 Million |
0.165x | +600.87% |
| 2008-12-31 | R$467.44 Million ≈ $91.72 Million |
R$11.03 Million ≈ $2.16 Million |
0.024x | +106.42% |
| 2007-12-31 | R$443.42 Million ≈ $87.01 Million |
R$-162.82 Million ≈ $-31.95 Million |
-0.367x | -50.79% |
| 2006-12-31 | R$404.47 Million ≈ $79.37 Million |
R$-98.50 Million ≈ $-19.33 Million |
-0.244x | -24.55% |
| 2005-12-31 | R$79.95 Million ≈ $15.69 Million |
R$-15.63 Million ≈ $-3.07 Million |
-0.196x | +56.65% |
| 2004-12-31 | R$67.69 Million ≈ $13.28 Million |
R$-30.53 Million ≈ $-5.99 Million |
-0.451x | -252.07% |
| 2003-12-31 | R$52.29 Million ≈ $10.26 Million |
R$15.51 Million ≈ $3.04 Million |
0.297x | -- |
About Profarma Distribuidora de Produtos Farmacêuticos S.A
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It provides pharmaceutical, personal hygiene, and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorpor… Read more